Keyes Jason A has filed 24 insider transactions across 2 companies since January 2022.
Most recent transaction: a grant/award of 15000 shares of ACTUATE THERAPEUTICS, INC. ($ACTU) on May 22, 2025.
Activity breakdown: 0 open-market purchases and 4 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 22, 2025 | ACTUATE THERAPEUTICS, INC. | $ACTU | Keyes Jason A | Director | A | Stock Options | 15000 | $0.00 | 15,000.0000 | 19,531,636 | 9999.99% | 0.08% |
| Feb. 14, 2025 | Equillium, Inc. | $EQ | Keyes Jason A | Chief Financial Officer | A | Employee Stock Option (right to buy) | 70000 | $0.00 | 70,000.0000 | 35,357,641 | 9999.99% | 0.20% |
| Feb. 14, 2025 | Equillium, Inc. | $EQ | Keyes Jason A | Chief Financial Officer | D | Employee Stock Option (right to buy) | 70000 | $0.00 | 0.0000 | 35,357,641 | 100.00% | 0.20% |
| Feb. 14, 2025 | Equillium, Inc. | $EQ | Keyes Jason A | Chief Financial Officer | A | Employee Stock Option (right to buy) | 90000 | $0.00 | 90,000.0000 | 35,357,641 | 9999.99% | 0.25% |
| Feb. 14, 2025 | Equillium, Inc. | $EQ | Keyes Jason A | Chief Financial Officer | D | Employee Stock Option (right to buy) | 90000 | $0.00 | 0.0000 | 35,357,641 | 100.00% | 0.25% |
| Feb. 14, 2025 | Equillium, Inc. | $EQ | Keyes Jason A | Chief Financial Officer | A | Employee Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 35,357,641 | 9999.99% | 0.28% |
| Feb. 14, 2025 | Equillium, Inc. | $EQ | Keyes Jason A | Chief Financial Officer | D | Employee Stock Option (right to buy) | 100000 | $0.00 | 0.0000 | 35,357,641 | 100.00% | 0.28% |
| Feb. 14, 2025 | Equillium, Inc. | $EQ | Keyes Jason A | Chief Financial Officer | A | Employee Stock Option (right to buy) | 125000 | $0.00 | 125,000.0000 | 35,357,641 | 9999.99% | 0.35% |
| Feb. 14, 2025 | Equillium, Inc. | $EQ | Keyes Jason A | Chief Financial Officer | D | Employee Stock Option (right to buy) | 125000 | $0.00 | 0.0000 | 35,357,641 | 100.00% | 0.35% |
| Feb. 14, 2025 | Equillium, Inc. | $EQ | Keyes Jason A | Chief Financial Officer | D | Employee Stock Option (right to buy) | 175000 | $0.00 | 0.0000 | 35,357,641 | 100.00% | 0.49% |
| Feb. 14, 2025 | Equillium, Inc. | $EQ | Keyes Jason A | Chief Financial Officer | A | Employee Stock Option (right to buy) | 175000 | $0.00 | 175,000.0000 | 35,357,641 | 9999.99% | 0.49% |
| Jan. 23, 2025 | Equillium, Inc. | $EQ | Keyes Jason A | Chief Financial Officer | S | Common Stock | 10000 | $0.65 | 126,633.0000 | 35,357,641 | 7.32% | 0.03% |
| Dec. 10, 2024 | Equillium, Inc. | $EQ | Keyes Jason A | Chief Financial Officer | A | Common Stock | 15000 | $0.54 | 136,633.0000 | 35,424,388 | 12.33% | 0.04% |
| Jan. 2, 2025 | Equillium, Inc. | $EQ | Keyes Jason A | Chief Financial Officer | A | Employee Stock Option (right to buy) | 175000 | $0.00 | 175,000.0000 | 35,357,641 | 9999.99% | 0.49% |
| Nov. 14, 2024 | Equillium, Inc. | $EQ | Keyes Jason A | Chief Financial Officer | S | Common Stock | 10000 | $0.70 | 121,633.0000 | 35,424,388 | 7.60% | 0.03% |
| Sept. 26, 2024 | Equillium, Inc. | $EQ | Keyes Jason A | Chief Financial Officer | S | Common Stock | 10000 | $0.81 | 131,633.0000 | 34,726,384 | 7.06% | 0.03% |
| Aug. 12, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Keyes Jason A | Director | A | Non-Qualified Stock Options | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| July 16, 2024 | Equillium, Inc. | $EQ | Keyes Jason A | Chief Financial Officer | S | Common Stock | 10000 | $0.87 | 141,633.0000 | 34,726,384 | 6.59% | 0.03% |
| June 9, 2023 | Equillium, Inc. | $EQ | Keyes Jason A | Chief Financial Officer | A | Common Stock | 15000 | $0.56 | 127,828.0000 | 0 | 13.29% | 0.00% |
| Dec. 8, 2023 | Equillium, Inc. | $EQ | Keyes Jason A | Chief Financial Officer | A | Common Stock | 8805 | $0.58 | 136,633.0000 | 0 | 6.89% | 0.00% |
| Jan. 2, 2024 | Equillium, Inc. | $EQ | Keyes Jason A | Chief Financial Officer | A | Employee Stock Option (right to buy) | 175000 | $0.00 | 175,000.0000 | 34,726,384 | 9999.99% | 0.50% |
| Jan. 19, 2022 | Equillium, Inc. | $EQ | Keyes Jason A | Chief Financial Officer | A | Employee Stock Option (right to buy) | 125000 | $0.00 | 125,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 9, 2022 | Equillium, Inc. | $EQ | Keyes Jason A | Chief Financial Officer | A | Common Stock | 4444 | $1.19 | 112,828.0000 | 0 | 4.10% | 0.00% |
| Jan. 3, 2023 | Equillium, Inc. | $EQ | Keyes Jason A | Chief Financial Officer | A | Employee Stock Option (right to buy) | 175000 | $0.00 | 175,000.0000 | 0 | 9999.99% | 0.00% |